Key Takeaways:
- Ensign Group posted adjusted EPS of $1.92, beating the $1.85 consensus
- Revenue rose 17.3% year over year to $1.44 billion
- The company raised 2026 EPS guidance to $7.75-$7.85 per share
Back
Ensign Group beats Q2 estimates, raises 2026 guidance on occupancy gains
Ensign Group Inc. reported second-quarter adjusted earnings of $1.92 per share, topping the $1.85 consensus estimate, as occupancy rates climbed and the company accelerated its acquisition pipeline.
"The strength of our model ultimately depends on the quality and stability of our people," Chief Executive Officer Barry Port said. "We continue to see strong demand across our portfolio, improving occupancy and skilled mix."
Revenue reached $1.44 billion in the quarter ended June 30, essentially matching the $1.44 billion consensus estimate and rising 17.3% from $1.23 billion a year earlier. Same-facility occupancy jumped 2.2 percentage points to 84.1%, while skilled mix by nursing revenue expanded to 51% from 50.1%. The company added 20 new skilled nursing operations during the quarter, all of which included real estate assets.
The company raised its full-year 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from a prior range of $7.48 to $7.62, implying 18.7% growth from 2025. Annual revenue guidance was lifted to $5.87 billion to $5.92 billion, from $5.81 billion to $5.86 billion. Ensign now operates 398 healthcare facilities across 17 states, with 183 owned real estate assets.
The guidance raise signals management expects the occupancy recovery and acquisition momentum to continue through the second half of the year. Investors will watch the company's Q3 earnings call for updates on the integration of recently acquired facilities and same-facility occupancy trends.
This article is for informational purposes only and does not constitute investment advice.
